Unibest
← Back to patent-cliff list

CAS 114623-14-2

[3-(4-Bromophenyl)-2,1-benzoxazol-7-yl]acetic acid

Codes: Bromfenac Sodium-043

Application context (from source-drug indications)

Inflammatory diseaseBromfenac SodiumPostoperative painBromfenac Sodium眼睛发炎Bromfenac Sodium眼睛疼痛Bromfenac SodiumDry eye syndromeBromfenac Sodium黄斑水肿Bromfenac Sodium

Source drugs (routes using this intermediate)

DrugTierExpiry
Bromfenac SodiumTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Bromfenac SodiumOptimised routesteps: 2total yield: 34.3g(Bromfenac Sodium (API))
2-(4-Bromophenyl)acetonitrile→2-(2-Nitrophenyl)acetic acid→[3-(4-Bromophenyl)-2,1-benzoxazol-7-yl]acetic acid

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.